Evidence of subgroup-specific treatment effect in the absence of an overall effect: is there really a contradiction?

Low HDL Cholesterol, Metformin Use, and Cancer Risk in Type 2 Diabetes: The Hong Kong Diabetes Registry

(2010) X. Yang et al.   DIABETES CARE

Mitigating Systematic Measurement Error in Comparative Effectiveness Research in Heterogeneous Populations

(2010) Adam C. Carle   MEDICAL CARE

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

(2009) D. N. Juurlink et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Interaction Reaction

(2009) Jay S. Kaufman   EPIDEMIOLOGY

When One Depends on the Other

(2009) Mirjam J. Knol et al.   EPIDEMIOLOGY

Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis

(2008) Diane Lacaille et al.   ARTHRITIS AND RHEUMATISM

Steroid-sparing effects of methotrexate in systemic lupus erythematosus: A double-blind, randomized, placebo-controlled trial

(2008) Paul R. Fortin et al.   ARTHRITIS AND RHEUMATISM

Subgroup-Specific Associations in the Face of Overall Null Results: Should We Rush In or Fear to Tread?

(2008) N. S. Weiss   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Interactions in Epidemiology: Relevance, Identification, and Estimation

(2008) Sander Greenland   EPIDEMIOLOGY

Experimental design and interaction analysis of combination studies of drugs with log‐linear dose responses

(2008) Hong‐Bin Fang et al.   STATISTICS IN MEDICINE